tradingkey.logo

Sotera Health Co

SHC
19.200USD
+0.390+2.07%
Close 01/09, 16:00ETQuotes delayed by 15 min
5.45BMarket Cap
98.30P/E TTM

Sotera Health Co

19.200
+0.390+2.07%

More Details of Sotera Health Co Company

Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions and lab testing and advisory services for the healthcare industry. The Company’s segments include Sterigenics, Nordion and Nelson Labs. The Sterigenics business provides outsourced terminal sterilization and irradiation services for the medical device, pharmaceutical, food safety and advanced applications markets using three technologies: gamma irradiation, ethylene oxide (EO) processing and E-beam irradiation. Nordion business is a global provider of Co-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. In addition, Nordion is a global provider of gamma irradiation systems. Nelson Labs business provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.

Sotera Health Co Info

Ticker SymbolSHC
Company nameSotera Health Co
IPO dateNov 20, 2020
CEOPetras (Michael B)
Number of employees3000
Security typeOrdinary Share
Fiscal year-endNov 20
Address9100 South Hills Blvd, Suite 300
CityBROADVIEW HEIGHTS
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code44147
Phone14402621410
Websitehttps://soterahealth.com/
Ticker SymbolSHC
IPO dateNov 20, 2020
CEOPetras (Michael B)

Company Executives of Sotera Health Co

Name
Name/Position
Position
Shareholding
Change
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
125.96K
+19132.00%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
80.78K
+19132.00%
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
80.78K
+19132.00%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
39.22K
+19132.00%
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
13.71K
-11508.00%
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--
Mr. Constantine S. (Dean) Mihas
Mr. Constantine S. (Dean) Mihas
Independent Director
Independent Director
--
--
Dr. David E. Wheadon, M.D.
Dr. David E. Wheadon, M.D.
Independent Director
Independent Director
--
--
Mr. Sean L. Cunningham
Mr. Sean L. Cunningham
Independent Director
Independent Director
--
--
Mr. Michael B. Petras, Jr.
Mr. Michael B. Petras, Jr.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Ann R. Klee
Ms. Ann R. Klee
Independent Director
Independent Director
125.96K
+19132.00%
Mr. Ruoxi Chen
Mr. Ruoxi Chen
Independent Director
Independent Director
80.78K
+19132.00%
Mr. Vincent K. (Vince) Petrella, CPA
Mr. Vincent K. (Vince) Petrella, CPA
Lead Independent Director
Lead Independent Director
80.78K
+19132.00%
Ms. Karen A. Flynn
Ms. Karen A. Flynn
Independent Director
Independent Director
39.22K
+19132.00%
Mr. Jonathan M. (Jon) Lyons
Mr. Jonathan M. (Jon) Lyons
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
13.71K
-11508.00%
Mr. James C. (Jim) Neary
Mr. James C. (Jim) Neary
Independent Director
Independent Director
--
--

Revenue Breakdown

Currency: USDUpdated: Tue, Jan 6
Currency: USDUpdated: Tue, Jan 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
616.68M
56.04%
Canada
208.89M
18.98%
Europe
196.01M
17.81%
Other
78.86M
7.17%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Fri, Nov 21
Updated: Fri, Nov 21
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Warburg Pincus LLC
12.00%
Darsana Capital Partners LP
8.80%
GTCR Golder Rauner, LLC
8.00%
The Vanguard Group, Inc.
5.78%
BlackRock Institutional Trust Company, N.A.
4.87%
Other
60.54%
Shareholders
Shareholders
Proportion
Warburg Pincus LLC
12.00%
Darsana Capital Partners LP
8.80%
GTCR Golder Rauner, LLC
8.00%
The Vanguard Group, Inc.
5.78%
BlackRock Institutional Trust Company, N.A.
4.87%
Other
60.54%
Shareholder Types
Shareholders
Proportion
Hedge Fund
26.25%
Investment Advisor
20.49%
Private Equity
20.01%
Investment Advisor/Hedge Fund
9.59%
Individual Investor
2.34%
Research Firm
0.75%
Pension Fund
0.42%
Sovereign Wealth Fund
0.35%
Bank and Trust
0.24%
Other
19.56%

Institutional Shareholding

Updated: Thu, Jan 1
Updated: Thu, Jan 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
488
222.56M
78.34%
-28.75M
2025Q3
470
259.09M
91.20%
-33.54M
2025Q2
470
278.88M
98.25%
-13.55M
2025Q1
484
279.71M
98.54%
-14.16M
2024Q4
491
273.89M
96.62%
-15.65M
2024Q3
489
274.82M
97.04%
-16.48M
2024Q2
489
271.96M
96.07%
-20.06M
2024Q1
463
270.40M
95.52%
-12.51M
2023Q4
463
265.31M
93.87%
-20.11M
2023Q3
459
263.78M
93.33%
-20.82M
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Warburg Pincus LLC
34.10M
12%
-9.72M
-22.18%
Dec 03, 2025
Darsana Capital Partners LP
25.00M
8.8%
+4.99M
+24.94%
Sep 30, 2025
GTCR Golder Rauner, LLC
22.74M
8%
-6.48M
-22.18%
Dec 03, 2025
The Vanguard Group, Inc.
16.43M
5.78%
+1.56M
+10.50%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
13.84M
4.87%
+1.42M
+11.47%
Sep 30, 2025
Sculptor Capital Management, Inc
13.34M
4.7%
+1.84M
+16.02%
Sep 30, 2025
Sessa Capital
9.92M
3.49%
+3.62M
+57.44%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
9.22M
3.25%
+165.53K
+1.83%
Sep 30, 2025
Sachem Head Capital Management LP
7.91M
2.78%
--
--
Sep 30, 2025
Janus Henderson Investors
6.46M
2.27%
+406.66K
+6.72%
Sep 30, 2025
View more

Related ETFs

Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
Brandes US Small-Mid Cap Value ETF
1.33%
First Trust Health Care Alphadex Fund
0.92%
Harbor Long-Short Equity ETF
0.56%
Gotham 1000 Value ETF
0.23%
Timothy Plan US Small Cap Core ETF
0.18%
Nuveen ESG Small-Cap ETF
0.16%
BNY Mellon US Small Cap Core Equity ETF
0.12%
WisdomTree US MidCap Fund
0.12%
Strive Small-Cap ETF
0.11%
John Hancock Multifactor Small Cap ETF
0.11%
View more
Brandes US Small-Mid Cap Value ETF
Proportion1.33%
First Trust Health Care Alphadex Fund
Proportion0.92%
Harbor Long-Short Equity ETF
Proportion0.56%
Gotham 1000 Value ETF
Proportion0.23%
Timothy Plan US Small Cap Core ETF
Proportion0.18%
Nuveen ESG Small-Cap ETF
Proportion0.16%
BNY Mellon US Small Cap Core Equity ETF
Proportion0.12%
WisdomTree US MidCap Fund
Proportion0.12%
Strive Small-Cap ETF
Proportion0.11%
John Hancock Multifactor Small Cap ETF
Proportion0.11%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
No Data
Date
Type
Ratio
No Data

FAQs

Who are the top five shareholders of Sotera Health Co?

The top five shareholders of Sotera Health Co are:
Warburg Pincus LLC holds 34.10M shares, accounting for 12.00% of the total shares.
Darsana Capital Partners LP holds 25.00M shares, accounting for 8.80% of the total shares.
GTCR Golder Rauner, LLC holds 22.74M shares, accounting for 8.00% of the total shares.
The Vanguard Group, Inc. holds 16.43M shares, accounting for 5.78% of the total shares.
BlackRock Institutional Trust Company, N.A. holds 13.84M shares, accounting for 4.87% of the total shares.

What are the top three shareholder types of Sotera Health Co?

The top three shareholder types of Sotera Health Co are:
Warburg Pincus LLC
Darsana Capital Partners LP
GTCR Golder Rauner, LLC

How many institutions hold shares of Sotera Health Co (SHC)?

As of 2025Q4, 488 institutions hold shares of Sotera Health Co, with a combined market value of approximately 222.56M, accounting for 78.34% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -12.86%.

What is the biggest source of revenue for Sotera Health Co?

In FY2024, the -- business generated the highest revenue for Sotera Health Co, amounting to -- and accounting for --% of total revenue.
KeyAI